EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries

PHASE4TerminatedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions
Pain
Interventions
DRUG

EXPAREL

TAP with EXPAREL

DRUG

Placebo

Placebo

Trial Locations (13)

10467

Montefiore Medical Center, The Bronx

15215

UPMC St. Margaret's Hospital, Pittsburgh

19107

Thomas Jefferson University, Philadelphia

27705

Duke University, Durham

31404

Memorial Health University Medical Center, Savannah

32792

Florida Hospital, Winter Park

40202

University of Louisville, Louisville

43210

The Ohio State University, Columbus

44111

Fairview Hospital, Cleveland

55404

University of Minnesota, Minneapolis

60208

Northwestern University, Chicago

77081

St. John Hospital, Houston

01210

Berkshire Medical Center, Pittsfield

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT01919190 - EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries | Biotech Hunter | Biotech Hunter